United States: Massachusetts
Chris Holding helms Goodwin Procter's antitrust practice in Boston, and the team works with lawyers out of the firm’s Washington, DC office to counsel clients in several industries. Recent work includes ongoing representation of Barbri, a company that prepares students for bar exams, in a lawsuit brought by a competitor against it and several universities for allegedly conspiring to push the rival out of business and maintain a monopoly in the testing market. That case is currently before the US Court of Appeals for the Second Circuit after a lower court dismissed the claims against Barbri. Goodwin also counsels generic drug maker Actavis in the Intuniv antitrust litigation before the US District Court for the District of Massachusetts. The case centres on allegations that Actavis and Shire conspired to keep a generic version of Intuniv from reaching the market. The firm also acts for Teva in another reverse payment case, in which Boehringer Ingelheim and Barr Pharmaceuticals – which Teva acquired – allegedly conspired to keep a generic version of Aggrenox off the market.
On the deal side, the firm put together a cross-office team to counsel Beth Israel Lahey Medical Center, Lahey Health System, New England Baptist Hospital, Mount Auburn Hospital and Anna Jaques Hospital in a transaction valued at about $5 billion that seeks to combine all of them to form Beth Israel Lahey Health. The FTC and the Massachusetts attorney general’s office are investigating the deal and had issued second request to all the parties at the time of writing.